RNS Number : 6685O
MiLOC Group Limited
13 June 2022

13 June 2022



("MiLOC", the "Group" or the "Company")




The Company announces that it plans to restructure the business of the Group. Due to the covid-19 pandemic in Hong Kong, following the suspension of the Traditional Chinese Medicine Centre ("TCM Centre") since October 2021, the Company decided to officially close the TCM Centre. The Company believes that by closing the TCM Centre, it can better utilise the capital resources of the Company and focus on more profitable business lines which includes, but not limited to, the sales and distribution of the designer products with our Partner, CRUSHMETRIC Limited.


The Company has shifted more resources to the business of CRUSHMETRIC SwitchPen, through online (currently mainly through and offline platforms. We expect to launch more products of CRUSHMETRIC in the foreseeable future including but not limited to special designed stools, drinks, etc. We expect the revenue in 2022 to grow and come out of the year stronger both organisationally and financially.


As announced on 2 March 2022, the Company's wholly-owned subsidiary was granted the exclusive distribution rights by CRUSHMETRIC Limited.


In due course, the Company may propose a resolution to shareholders, together with an explanatory circular, proposing the change of the Company's business to include the sales and distribution agreement, as the Company moves away from Traditional Chinese Medicine ("TCM").


The directors of the Company accept responsibility for the contents of this announcement.


For further information, please contact:-



ONG Ban Poh Michael - Chief Executive Officer

Lilian Lo - Acting Chief Financial Officer





Tel: +852 2110 4221


AQSE Growth Market Corporate Adviser


Guy Miller

Mark Anwyl

Tel: +44 (0) 20 7469 0930


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.